2019
DOI: 10.1038/s41598-019-40637-z
|View full text |Cite
|
Sign up to set email alerts
|

Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells

Abstract: Over the past decade, cold atmospheric plasmas have shown promising application in cancer therapy. The therapeutic use of plasma-activated media is a topic addressed in an emerging field known as plasma pharmacy. In oncology, plasma-activated media are  used to harness the therapeutic effects of oxidant species when they come in contact with cancer cells. Among several factors that contribute to the anticancer effect of plasma-activated liquid media (PALM), H2O2 and NO derivatives likely play a key role in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
87
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(89 citation statements)
references
References 83 publications
2
87
0
Order By: Relevance
“…Within the tumor microenvironment, they recognize tumor antigens and lyse the target cells, helping the body to fight cancer using its endogenous weapons provided by the immune system. Using direct plasma treatment or plasma-conditioned liquids, ICD has been observed in vitro in a number of tumor cell types including, for instance, pancreatic cancer, colorectal cancer, lung cancer, and malignant melanoma [99,[131][132][133][134][135][136][137][138][139][140]. Due to the extensive poly-pragmasia of plasma sources used in the field of plasma medicine, the central mechanisms underlying plasma-induced ICD have not been commonly unraveled.…”
Section: Induction Of An Immune Response Through Cap Treatmentmentioning
confidence: 99%
“…Within the tumor microenvironment, they recognize tumor antigens and lyse the target cells, helping the body to fight cancer using its endogenous weapons provided by the immune system. Using direct plasma treatment or plasma-conditioned liquids, ICD has been observed in vitro in a number of tumor cell types including, for instance, pancreatic cancer, colorectal cancer, lung cancer, and malignant melanoma [99,[131][132][133][134][135][136][137][138][139][140]. Due to the extensive poly-pragmasia of plasma sources used in the field of plasma medicine, the central mechanisms underlying plasma-induced ICD have not been commonly unraveled.…”
Section: Induction Of An Immune Response Through Cap Treatmentmentioning
confidence: 99%
“…Cold atmospheric plasma (referred as 'plasma') is described as a room temperature ionized gas generated at atmospheric pressure. Plasma generates reactive oxygen and nitrogen species (RONS), which, once applied to cancer cells, have the potential to induce DNA damages leading to cell apoptosis [1] or cause immunogenic cell death [2][3][4]. More importantly, cancer cells appear to be more sensitive to plasma than healthy cells [5][6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the in vivo reduction of subcutaneously implanted tumors in nude mice from the ovary, glioma cells, and bladder cancer cells exposed to CAP or plasma‐activated liquid has also been demonstrated. And plasma‐activated liquid is expected to be an alternative therapy pathway for the deeper cancers . For clinical research, CAP has been verified as a safe and effective clinical intervention to treat head and neck cancer .…”
Section: Introductionmentioning
confidence: 99%